Response to comment on "NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis".
Level V
Where this comes from
- Record sourced from PubMed, PMID 27464746.
- Also identified by DOI 10.1126/scitranslmed.aag1805.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Multiple factors may affect the outcome of diabetic patients with cancer treated with antioxidant antidiabetic agents.
Medical subject headings
- Antioxidants
- Hypoglycemic Agents
- NF-E2-Related Factor 2
- Neoplasms